Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. market cap "Mega ≥$200B"、profit streak "Full 10 yr"、No report yetで絞り込み:43 match(絞り込みを解除)。

# 銘柄 Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin レポート FY
1 Visa Inc. Class A V · 米国株 $684B
95/100 卓越
35.7%low 18.2% 10 yr+ 0.1× 81% FY2025
2 KLA Corporation KLAC · 米国株 $239B
93/100 卓越
55.9%low 44.2% 10 yr+ 0.2× 61% FY2026
3 Kweichow Moutai Co Ltd 600519 · 上海 $236B
93/100 卓越
30.8%low 22.9% 10 yr+ Net cash 90% FY2025
4 ASML Holding NV ADR ASML · 米国株 $626B
92/100 卓越
36.5%low 15.9% 10 yr+ Net cash 49% FY2025
5 Applied Materials Inc AMAT · 米国株 $403B
92/100 卓越
38.9%low 23.8% 10 yr+ Net cash 46% FY2025
6 Roche Holding AG ROG · SW $326B
92/100 卓越
39.6%low 26.1% 10 yr+ 0.5× 72% FY2025
7 Microsoft Corporation MSFT · 米国株 $3.5T
91/100 卓越
34.6%low 20.0% 10 yr+ 0.1× 68% FY2026
8 Lam Research Corp LRCX · 米国株 $367B
90/100 卓越
48.3%low 24.3% 10 yr+ Net cash 47% FY2026
9 American Express Company AXP · 米国株 $227B
89/100 卓越
27.8%low 13.6% 10 yr+ 0.3× 87% FY2025
10 LOréal S.A. OR · パリ $222B
88/100 卓越
16.5%low 12.3% 10 yr+ 0.1× 73% FY2025
11 Novo Nordisk A/S NOVO-B · CO $210B
88/100 卓越
59.3%low 52.8% 10 yr+ 0.5× 84% FY2025
12 Cisco Systems Inc CSCO · 米国株 $457B
87/100 卓越
22.4%low 0.3% 10 yr+ 0.3× 63% FY2025
13 Costco Wholesale Corp COST · 米国株 $422B
87/100 卓越
25.4%low 19.5% 10 yr+ Net cash 13% FY2025
14 Mastercard Inc MA · 米国株 $502B
86/100 卓越
60.0%low 60.0% 10 yr+ 1.0× 77% FY2025
15 Alphabet Inc Class C GOOG · 米国株 $4.4T
85/100 卓越
21.7%low 8.3% 10 yr+ Net cash 57% FY2025
16 UnitedHealth Group Incorporated UNH · 米国株 $376B
84/100 卓越
21.4%low 12.8% 10 yr+ 0.5× 23% FY2025
17 Procter & Gamble Company PG · 米国株 $335B
84/100 卓越
26.6%low 8.3% 10 yr+ 0.4× 50% FY2026
18 Apple Inc. AAPL · 米国株 $4.5T
83/100 卓越
54.7%low 35.6% 10 yr+ 0.8× 41% FY2025
19 LVMH Moët Hennessy - Louis Vuitton MC · パリ $253B
83/100 卓越
19.2%low 12.1% 10 yr+ 0.3× 67% FY2025
20 Johnson & Johnson JNJ · 米国株 $618B
82/100 卓越
25.5%low 2.2% 10 yr+ 0.3× 69% FY2025
21 Texas Instruments Incorporated TXN · 米国株 $252B
82/100 卓越
46.2%low 28.4% 10 yr+ 0.6× 63% FY2025
22 Nestle S.A. NESN · SW $265B
80/100 卓越
23.7%low 11.7% 10 yr+ 1.6× 48% FY2025
23 The Coca-Cola Company KO · 米国株 $377B
79/100 優良
36.8%low 7.3% 10 yr+ 1.0× 61% FY2025
24 The Home Depot Inc HD · 米国株 $337B
78/100 優良
60.0%low 60.0% 10 yr+ 5.0× 34% FY2026
25 Novartis AG NOVN · SW $306B
78/100 優良
20.9%low 9.0% 10 yr+ 0.6× 71% FY2025
26 SAP SE ADR SAP · 米国株 $231B
77/100 優良
12.6%low 5.7% 10 yr+ Net cash 71% FY2025
27 Philip Morris International Inc PM · 米国株 $297B
76/100 優良
49.2%low 24.0% 10 yr+ 60% FY2025
28 Netflix Inc NFLX · 米国株 $299B
74/100 優良
25.2%low 7.0% 10 yr+ 0.2× 40% FY2025
29 AbbVie Inc ABBV · 米国株 $443B
73/100 優良
54.6%low 35.2% 10 yr+ 71% FY2025
30 Merck & Company Inc MRK · 米国株 $307B
71/100 優良
24.4%low 1.0% 10 yr+ 0.7× 70% FY2025
31 International Business Machines IBM · 米国株 $211B
71/100 優良
34.1%low 7.5% 10 yr+ 1.6× 52% FY2025
32 MediaTek Inc 2454 · 台湾株 $226B
70/100 優良
17.2%low 7.4% 10 yr+ Net cash 41% FY2025
33 Walmart Inc. WMT · 米国株 $885B
69/100 優良
16.0%low 8.4% 10 yr+ 0.6× 25% FY2026
34 Thermo Fisher Scientific Inc TMO · 米国株 $213B
69/100 優良
13.3%low 8.8% 10 yr+ 0.5× 44% FY2025
35 Morgan Stanley MS · 米国株 $331B
68/100 優良
11.1%low 7.9% 10 yr+ Net cash 77% FY2025
36 Amgen Inc AMGN · 米国株 $208B
67/100 優良
51.4%low 7.8% 10 yr+ 5.3× 76% FY2025
37 Oracle Corporation ORCL · 米国株 $374B
65/100 優良
46.3%low 7.8% 10 yr+ 2.9× 76% FY2026
38 AstraZeneca PLC AZN · LSE $249B
64/100 標準
15.3%low 0.3% 10 yr+ 0.5× 72% FY2025
39 Siemens AG ADR SIEGY · 米国株 $249B
63/100 標準
13.4%low 7.6% 10 yr+ 0.6× 35% FY2025
40 Samsung Electronics Co Ltd 005930 · 韓国株 $1.7T
57/100 標準
12.1%low 4.1% 10 yr+ Net cash 38% FY2025
41 Goldman Sachs Group Inc GS · 米国株 $309B
55/100 標準
10.7%low 5.2% 10 yr+ Net cash 65% FY2025
42 CNOOC Limited 600938 · 上海 $215B
52/100 標準
12.9%low 0.2% 10 yr+ Net cash 74% FY2025
43 Linde plc Ordinary Shares LIN · 米国株 $221B
48/100 やや弱い
13.9%low 4.7% 10 yr+ 0.6× 32% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.